Evidence map›Paper›PMID 39198167›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Deterioration of Vocal Cord Paralysis after COVID-19 Infection in Multiple System Atrophy.

Yosuke Takeuchi, Teruaki Masuda, Noriyuki Kimura, Takeshi Mizukami, Kazuhiro Yoshinaga, Takashi Hirano, Masashi Suzuki, Etsuro Matsubara

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yosuke TakeuchiDepartment of Neurology, Faculty of Medicine, Oita University, Japan.
Teruaki MasudaDepartment of Neurology, Faculty of Medicine, Oita University, Japan.
Noriyuki KimuraDepartment of Neurology, Faculty of Medicine, Oita University, Japan.
Takeshi MizukamiDepartment of Neurology, Faculty of Medicine, Oita University, Japan.
Kazuhiro YoshinagaDepartment of Otolaryngology-Head and Neck Surgery, Oita University, Japan.
Takashi HiranoDepartment of Otolaryngology-Head and Neck Surgery, Oita University, Japan.
Masashi SuzukiDepartment of Otolaryngology-Head and Neck Surgery, Oita University, Japan.
Etsuro MatsubaraDepartment of Neurology, Faculty of Medicine, Oita University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple system atrophy (MSA) is a progressive neurodegenerative disease that often causes vocal cord paralysis (VCP), Parkinsonism, cerebellar ataxia, and autonomic dysfunction. VCP is the most fatal symptom that affects the prognosis of patients with MSA. Coronavirus disease 2019 (COVID-19) is often associated with neurological complications and it has recently been reported to induce VCP in patients without neurodegenerative diseases. We herein present two cases of patients with MSA in whom VCP worsened after COVID-19 and this led to the need to perform emergency tracheostomies. As VCP may deteriorate after COVID-19 in patients with MSA, it is important to prevent COVID-19 in these patients and closely monitor such patients for any signs of VCP deterioration post-infection to improve their prognosis.

Indexed as

COVID-19Multiple System AtrophyVocal Cord ParalysisAgedFemaleHumansMaleMiddle AgedSARS-CoV-2Tracheostomycoronavirus disease 2019multiple system atrophytracheotomyvocal cord paralysis

Identifiers

PMID39198167
PMCPMC11604396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.